Systemic inflammatory response syndrome

Seminars in Pediatric Infectious Diseases

Volumn 12, Issue 1, 2001, Pages 5-16

  Adams Chapman, Ira ^a   Stoll, Barbara J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; NITRIC OXIDE; PROSTACYCLIN DERIVATIVE; PROSTAGLANDIN E2; THROMBIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE A2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

BRAIN INJURY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EARLY DIAGNOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFLAMMATION; MULTIPLE ORGAN FAILURE; PREMATURE LABOR; PREMATURITY; PROTEIN EXPRESSION; REVIEW; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

EID: 0035135060     PISSN: 10451870     EISSN: None     Source Type: Journal    
DOI: 10.1053/spid.2001.19230     Document Type: Article

References (92)

1. Bacterial sepsis and meningitis
2. Correlation of plasma cytokine elevations with mortality rate in children with sepsis
3. Circulating methemoglobin and nitrite/nitrate concentrations as indicators of nitric oxide overproduction in critically ill children with septic shock
4. The compensatory anti-inflammatory cytokine interleukin 10 response in pediatric sepsis-induced multiple organ failure
5. National Center for Health Statistics: Mortality patterns - United States, 1990
6. Increase in national hospital discharge survey rates for septicemia - United States, 1979-1987
7. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
8. Increased serum nitrite and nitrate concentrations in children with sepsis
9. Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)
10. Sir Isaac Newton sepsis SIRS, and CARS
11. The epidemiology of bacterial sepsis
12. The pathogenesis of sepsis
13. Comparison of procalcitonin with interleukin 8, C-reactive protein, and differential white blood cell count for the early diagnostic of bacterial infections in newborn infants
14. Interleukin-6: A sensitive parameter for the early diagnosis of neonatal bacterial infection
15. The neonatal blood count in health and disease. Reference values for neutrophilic cells
16. Accuracy of leukocyte indices and C-reactive protein for diagnosis of neonatal sepsis: A critical review
17. The predictive value of CRP and I/T ratio in neonatal infection
18. Acute in vivo effects of human recombinant tumor necrosis factor
19. Diagnostic value of plasma levels of tumor necrosis factor a and interleukin- 6 in newborns with sepsis
20. Plasma tumor necrosis factor and mortality in critically ill septic patients
21. Granulocyte elastase, tumor necrosis factor-alpha and urokinase levels as prognostic markers in severe infections
22. Tumor necrosis factor and interleukin- 1 in the serum of children with severe infectious purpura
23. Significance of serial C-reactive protein response in neonatal infections and other disorders
24. Diagnostic audit of C-reactive protein in neonatal infection
25. Interleukin-1 receptor antagonist and interleukin- 6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation
26. Interleukin- 6 concentrations in neonates evaluated for sepsis
27. Reduction of unnecessary antibiotic therapy in newborn infants using interleukin-8 and C-reactive protein as markers of bacterial infections
28. Increased plasma concentration of interleukin-1 receptor antagonist in neonatal sepsis
29. Tumor necrosis factor-α, interleukin-1α, and interleukin-6 plasma levels in neonatal sepsis
30. Interleukin- 6 in neonates with early and late onset infection
31. Plasma IL-8 and IL- 6 levels can be used to define a group with low risk of septicacmia among cancer patients with fever and neutropenia
32. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients
33. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Feγ receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia
34. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL- 10 produced by monocytes
35. Interleukin- 10 production during septicaemia
36. Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome
37. Predictive value of soluble immunological mediators in neonatal infection
38. Soluble interleukin-2 receptor as a predictor of neonatal sepsis
39. Plasma nitric oxide levels in newborn infants with sepsis
40. Inflammatory cytokines and nitric oxide responses in pediatric sepsis and organ failure
41. Premature labor and intra-amniotic infection
42. A review of premature birth and subclinical infection
43. Association between bacterial vaginosis and preterm delivery of a low birth weight infant
44. Sexually transmitted diseases and adverse outcomes of pregnancy
45. Infection in the pathogenesis of preterm labor
46. Role of prostaglandins, prostacyclin, and thromboxanes in the physiologic control of the uterus and in parturition
47. The mechanisms of human parturition
48. Initiation of human parturition. I. Mechanism of action of arachidonic acid
49. Amniotic fluid prostaglandin E2 in preterm labor. Prostaglandins
50. Prostaglandin F metabolite concentrations as a prognostic factor in preterm labor
51. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition
52. The fetal inflammatory response syndrome
53. The natural interleukin-1 receptor antagonist in the fetal, maternal, and amniotic fluid compartments: The effect of gestational age, fetal gender, and intrauterine infection
54. Is amniotic fluid analysis the key to preterm labor? A model using interleukin- 6 for predicting rapid delivery
55. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1 beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy
56. Maternal infection and cerebral palsy in infants of normal birth weight
57. Interferons and cerebral palsy
58. Intracranial hemorrhage: Subdural, primary subarachnoid, intracellular, intraventricular (term infant), and miscellaneous
59. Periventricular leukomalacia and intraventricular hemorrhage in the preterm neonate
60. Cranial ultrasound prediction of disabling and nondisabling cerebral palsy at age two in a low birth weight population
61. Ultrasound findings and clinical antecedents of cerebral palsy in very preterm infants
62. High expression of tumor necrosis factor-α and interleukin- 6 in periventricular leukomalacia
63. Immunohistochemical expression of tumor necrosis factor α in neonatal leukomalacia
64. Neonatal endotoxin encephalopathy
65. Cytokine release from microgila: Differential inhibition by pentoxifylline and dexamethasone
66. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn
67. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants
68. Antenatal origin of neurologic damage in newborn infants
69. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia
70. Elevated amniotic fluid interleukin-6 as a predictor of neonatal periventricular leukomalacia and intraventricular hemorrhage
71. Obstetric antecedents of intraventricular hemorrhage and perventricular leukomalacia in the low-birth-weigh neonate
72. Necrotizing enterocolitis in very low birth weight infants: Biodemographic and clinical correlates
73. The platelet-activating factor receptor antagonist WEB 2170 prevents neonatal necrotizing entercolitis in rats
74. The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis
75. Roles of nitric oxide synthases in platelet-activating factor-Induced intestinal necrosis in rats
76. Endogenous nitric oxide protects against platelet-activating factor induced bowel injury in the rat
77. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis
78. Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis
79. Neurodevelopmental and functional outcome of extremely-low-birth-weight (ELBW) infants in the NICHD Neonatal Research Network 1993-1994
80. Mechanisms initiating lung injury in the preterm
81. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease
82. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less
83. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia
84. Pivotal role of interleukin-8 in the acute respiratory distress syndrome and cerebral reperfusion injury
85. Increased activity of interleukin-6 but not tumor necrosis factor-α in lung lavage of premature infants is associated with development of broncho-pulmonary dysplasia
86. The effects of IL-10 on proinflammatory cytokine expression (IL-1β and IL-8) in hyaline membrane disease (HMD)
87. Association of Ureaplasma urealyticum colonization with chronic lung disease of prematurity: Results of a meta-analysis
88. Induction of human pulmonary fibroblast cytokines by hyperoxia and ureaplasma urealyticum
89. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops
90. Commentaries: Lung protective strategies of ventilation in the neonate: What are they?
91. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A randomized controlled trial
92. Cytokines